H 4494
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill prohibits pharmacy benefit managers (PBMs) from unfairly treating hospitals and patients who participate in the 340B drug discount program. Specifically, it prevents PBMs from charging these entities lower reimbursement rates, imposing fees based on 340B participation, or restricting access to pharmacies. The goal is to ensure equitable access to discounted medications for vulnerable healthcare providers and patients.
Key provisions
- PBMs cannot reimburse 340B covered entities at rates lower than those paid to non-340B entities.
- PBMs cannot assess fees or charges based on 340B participation.
- PBMs cannot restrict network participation based on 340B status.
- PBMs cannot require specific pharmacy contracts for 340B entities.
- PBMs cannot require modifiers for 340B claims unless paid by Medicaid.
- PBMs cannot impose coverage limitations or penalties on 340B drug purchases.
- PBMs cannot interfere with a patient’s choice to obtain 340B drugs.
Who is affected
- Hospitals
- Patients
- Pharmacy Benefit Managers (PBMs)
- 340B Covered Entities
- Pharmaceutical Manufacturers
Notable changes
- The bill aims to address potential discrimination against hospitals and patients involved in the 340B drug discount program.
- It clarifies PBMs’ obligations regarding reimbursement rates and fees associated with 340B drugs.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Joint Committee on Financial Services
Cosponsors
Brian W. Murray
James B. Eldridge
Michael O. Moore
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.4494 194th (Current)
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
View Text Print Preview Download PDF
Bill Information
Bill Information
Sponsor: Joint Committee on Financial Services Status: Referred to Joint Committee on Health Care Financing
Tabs
Bill History Cosponsors Committee Vote Committee Summary
Bill History
Displaying 5 actions for Bill H.4494
| Date | Branch | Action |
| 9/18/2025 | House | Reported from the committee on Financial Services |
| 9/18/2025 | House | New draft of H1274 |
| 9/18/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
Similar Bills
H.1274 194th (Current)
An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program
H.959 193rd (2023 - 2024)
An Act prohibiting discrimination against 340b drug discount program participants
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.